Cargando…

No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice

BACKGROUND: The NLRP3 inflammasome integrates several danger signals into the activation of innate immunity and inflammation by secreting IL-1β and IL-18. Most published data relate to the NLRP3 inflammasome in immune cells, but some reports claim similar roles in parenchymal, namely epithelial, cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunte, Sophie Carina, Marschner, Julian A., Klaus, Martin, Honda, Tâmisa, Li, Chenyu, Motrapu, Manga, Walz, Christoph, Angelotti, Maria Lucia, Antonelli, Giulia, Melica, Maria Elena, De Chiara, Letizia, Semeraro, Roberto, Nelson, Peter J., Anders, Hans-Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513077/
https://www.ncbi.nlm.nih.gov/pubmed/37744356
http://dx.doi.org/10.3389/fimmu.2023.1230050
_version_ 1785108489409921024
author Kunte, Sophie Carina
Marschner, Julian A.
Klaus, Martin
Honda, Tâmisa
Li, Chenyu
Motrapu, Manga
Walz, Christoph
Angelotti, Maria Lucia
Antonelli, Giulia
Melica, Maria Elena
De Chiara, Letizia
Semeraro, Roberto
Nelson, Peter J.
Anders, Hans-Joachim
author_facet Kunte, Sophie Carina
Marschner, Julian A.
Klaus, Martin
Honda, Tâmisa
Li, Chenyu
Motrapu, Manga
Walz, Christoph
Angelotti, Maria Lucia
Antonelli, Giulia
Melica, Maria Elena
De Chiara, Letizia
Semeraro, Roberto
Nelson, Peter J.
Anders, Hans-Joachim
author_sort Kunte, Sophie Carina
collection PubMed
description BACKGROUND: The NLRP3 inflammasome integrates several danger signals into the activation of innate immunity and inflammation by secreting IL-1β and IL-18. Most published data relate to the NLRP3 inflammasome in immune cells, but some reports claim similar roles in parenchymal, namely epithelial, cells. For example, podocytes, epithelial cells critical for the maintenance of kidney filtration, have been reported to express NLRP3 and to release IL-β in diabetic kidney disease, contributing to filtration barrier dysfunction and kidney injury. We questioned this and hence performed independent verification experiments. METHODS: We studied the expression of inflammasome components in human and mouse kidneys and human podocytes using single-cell transcriptome analysis. Human podocytes were exposed to NLRP3 inflammasome agonists in vitro and we induced diabetes in mice with a podocyte-specific expression of the Muckle-Wells variant of NLRP3, leading to overactivation of the Nlrp3 inflammasome (Nphs2Cre;Nlrp3(A350V)) versus wildtype controls. Phenotype analysis included deep learning-based glomerular and podocyte morphometry, tissue clearing, and STED microscopy of the glomerular filtration barrier. The Nlrp3 inflammasome was blocked by feeding ß-hydroxy-butyrate. RESULTS: Single-cell transcriptome analysis did not support relevant NLRP3 expression in parenchymal cells of the kidney. The same applied to primary human podocytes in which NLRP3 agonists did not induce IL-1β or IL-18 secretion. Diabetes induced identical glomerulomegaly in wildtype and Nphs2Cre;Nlrp3(A350V) mice but hyperfiltration-induced podocyte loss was attenuated and podocytes were larger in Nphs2Cre;Nlrp3(A350V) mice, an effect reversible with feeding the NLRP3 inflammasome antagonist ß-hydroxy-butyrate. Ultrastructural analysis of the slit diaphragm was genotype-independent hence albuminuria was identical. CONCLUSION: Podocytes express low amounts of the NLRP3 inflammasome, if at all, and do not produce IL-1β and IL-18, not even upon introduction of the A350V Muckle-Wells NLRP3 variant and upon induction of podocyte stress. NLRP3-mediated glomerular inflammation is limited to immune cells.
format Online
Article
Text
id pubmed-10513077
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105130772023-09-22 No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice Kunte, Sophie Carina Marschner, Julian A. Klaus, Martin Honda, Tâmisa Li, Chenyu Motrapu, Manga Walz, Christoph Angelotti, Maria Lucia Antonelli, Giulia Melica, Maria Elena De Chiara, Letizia Semeraro, Roberto Nelson, Peter J. Anders, Hans-Joachim Front Immunol Immunology BACKGROUND: The NLRP3 inflammasome integrates several danger signals into the activation of innate immunity and inflammation by secreting IL-1β and IL-18. Most published data relate to the NLRP3 inflammasome in immune cells, but some reports claim similar roles in parenchymal, namely epithelial, cells. For example, podocytes, epithelial cells critical for the maintenance of kidney filtration, have been reported to express NLRP3 and to release IL-β in diabetic kidney disease, contributing to filtration barrier dysfunction and kidney injury. We questioned this and hence performed independent verification experiments. METHODS: We studied the expression of inflammasome components in human and mouse kidneys and human podocytes using single-cell transcriptome analysis. Human podocytes were exposed to NLRP3 inflammasome agonists in vitro and we induced diabetes in mice with a podocyte-specific expression of the Muckle-Wells variant of NLRP3, leading to overactivation of the Nlrp3 inflammasome (Nphs2Cre;Nlrp3(A350V)) versus wildtype controls. Phenotype analysis included deep learning-based glomerular and podocyte morphometry, tissue clearing, and STED microscopy of the glomerular filtration barrier. The Nlrp3 inflammasome was blocked by feeding ß-hydroxy-butyrate. RESULTS: Single-cell transcriptome analysis did not support relevant NLRP3 expression in parenchymal cells of the kidney. The same applied to primary human podocytes in which NLRP3 agonists did not induce IL-1β or IL-18 secretion. Diabetes induced identical glomerulomegaly in wildtype and Nphs2Cre;Nlrp3(A350V) mice but hyperfiltration-induced podocyte loss was attenuated and podocytes were larger in Nphs2Cre;Nlrp3(A350V) mice, an effect reversible with feeding the NLRP3 inflammasome antagonist ß-hydroxy-butyrate. Ultrastructural analysis of the slit diaphragm was genotype-independent hence albuminuria was identical. CONCLUSION: Podocytes express low amounts of the NLRP3 inflammasome, if at all, and do not produce IL-1β and IL-18, not even upon introduction of the A350V Muckle-Wells NLRP3 variant and upon induction of podocyte stress. NLRP3-mediated glomerular inflammation is limited to immune cells. Frontiers Media S.A. 2023-08-23 /pmc/articles/PMC10513077/ /pubmed/37744356 http://dx.doi.org/10.3389/fimmu.2023.1230050 Text en Copyright © 2023 Kunte, Marschner, Klaus, Honda, Li, Motrapu, Walz, Angelotti, Antonelli, Melica, De Chiara, Semeraro, Nelson and Anders https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Kunte, Sophie Carina
Marschner, Julian A.
Klaus, Martin
Honda, Tâmisa
Li, Chenyu
Motrapu, Manga
Walz, Christoph
Angelotti, Maria Lucia
Antonelli, Giulia
Melica, Maria Elena
De Chiara, Letizia
Semeraro, Roberto
Nelson, Peter J.
Anders, Hans-Joachim
No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
title No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
title_full No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
title_fullStr No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
title_full_unstemmed No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
title_short No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
title_sort no nlrp3 inflammasome activity in kidney epithelial cells, not even when the nlrp3-a350v muckle-wells variant is expressed in podocytes of diabetic mice
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513077/
https://www.ncbi.nlm.nih.gov/pubmed/37744356
http://dx.doi.org/10.3389/fimmu.2023.1230050
work_keys_str_mv AT kuntesophiecarina nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT marschnerjuliana nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT klausmartin nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT hondatamisa nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT lichenyu nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT motrapumanga nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT walzchristoph nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT angelottimarialucia nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT antonelligiulia nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT melicamariaelena nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT dechiaraletizia nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT semeraroroberto nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT nelsonpeterj nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice
AT andershansjoachim nonlrp3inflammasomeactivityinkidneyepithelialcellsnotevenwhenthenlrp3a350vmucklewellsvariantisexpressedinpodocytesofdiabeticmice